MyCartis acquires ANTELOPE Dx platform technology

(20-12-2018) The biotech company MyCartis has announced the addition of a point-of-need testing technology, ANTELOPE Dx (developed at one of the research groups of NB-Photonics) to complement its immuno-assay technology offering.